FEDERICO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 61.397
EU - Europa 33.208
AS - Asia 25.786
SA - Sud America 3.953
AF - Africa 753
OC - Oceania 203
Continente sconosciuto - Info sul continente non disponibili 45
Totale 125.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 60.422
GB - Regno Unito 11.135
SG - Singapore 7.125
CN - Cina 6.901
IT - Italia 6.354
RU - Federazione Russa 3.657
HK - Hong Kong 3.297
BR - Brasile 2.971
VN - Vietnam 2.971
DE - Germania 2.601
SE - Svezia 2.571
FI - Finlandia 1.730
TR - Turchia 1.471
UA - Ucraina 1.443
FR - Francia 1.260
KR - Corea 704
IN - India 583
BG - Bulgaria 546
CA - Canada 448
JP - Giappone 448
NL - Olanda 370
ID - Indonesia 366
BD - Bangladesh 361
AR - Argentina 325
IE - Irlanda 265
MX - Messico 243
IQ - Iraq 208
ZA - Sudafrica 204
ES - Italia 186
AU - Australia 183
AE - Emirati Arabi Uniti 165
PK - Pakistan 163
EC - Ecuador 144
PL - Polonia 139
BE - Belgio 138
CL - Cile 131
AT - Austria 130
CO - Colombia 130
MA - Marocco 129
MY - Malesia 120
BZ - Belize 109
CZ - Repubblica Ceca 105
EG - Egitto 103
SA - Arabia Saudita 99
CH - Svizzera 90
RO - Romania 86
VE - Venezuela 84
PH - Filippine 81
UZ - Uzbekistan 80
IR - Iran 75
TN - Tunisia 66
IL - Israele 65
LT - Lituania 64
TH - Thailandia 64
NP - Nepal 61
TW - Taiwan 58
KE - Kenya 57
DZ - Algeria 55
PY - Paraguay 46
JO - Giordania 44
PE - Perù 43
PT - Portogallo 43
AZ - Azerbaigian 41
UY - Uruguay 38
DK - Danimarca 35
CR - Costa Rica 34
BO - Bolivia 32
NO - Norvegia 30
EU - Europa 29
DO - Repubblica Dominicana 28
HU - Ungheria 28
KZ - Kazakistan 28
ET - Etiopia 26
GR - Grecia 26
OM - Oman 26
JM - Giamaica 24
KG - Kirghizistan 24
EE - Estonia 22
PA - Panama 20
LB - Libano 19
RS - Serbia 19
BH - Bahrain 17
NZ - Nuova Zelanda 17
AL - Albania 16
LY - Libia 16
AM - Armenia 15
LV - Lettonia 15
MD - Moldavia 15
HR - Croazia 14
SI - Slovenia 14
AO - Angola 13
BY - Bielorussia 13
GE - Georgia 13
PS - Palestinian Territory 13
HN - Honduras 12
KW - Kuwait 12
LK - Sri Lanka 12
SK - Slovacchia (Repubblica Slovacca) 12
NG - Nigeria 11
PR - Porto Rico 11
Totale 125.106
Salva come PNG Salva come JPEG
Città #
Southend 8.520
Fairfield 6.451
Ashburn 6.024
Santa Clara 4.751
Singapore 4.490
Woodbridge 3.561
Hong Kong 3.182
Houston 2.944
Chandler 2.932
Moscow 2.713
Jacksonville 2.633
Seattle 2.416
Wilmington 2.272
Dearborn 2.118
Cambridge 2.086
Hefei 2.033
San Jose 1.703
Ann Arbor 1.639
Beijing 1.403
Nyköping 1.352
London 1.303
Helsinki 1.206
Los Angeles 1.008
Ho Chi Minh City 886
Chicago 882
Council Bluffs 879
The Dalles 818
Izmir 783
Hanoi 654
Frankfurt am Main 648
San Diego 625
Princeton 595
Seoul 588
New York 584
Milan 548
Sofia 529
Eugene 477
Modena 471
Buffalo 440
Lauterbourg 396
Shanghai 343
Salt Lake City 334
Dallas 317
Redwood City 308
Rome 306
Des Moines 275
São Paulo 267
Jakarta 263
Columbus 241
Tokyo 222
Dublin 219
Munich 215
Dong Ket 206
Bremen 169
Phoenix 161
Elk Grove Village 150
Boardman 147
Falls Church 143
Orem 139
Bologna 136
Da Nang 129
Tampa 129
Haiphong 116
Manchester 114
Norwalk 109
Belize City 106
Atlanta 101
Rio de Janeiro 101
Toronto 99
Verona 97
Turin 95
San Francisco 94
Warsaw 94
Brooklyn 91
Guangzhou 91
Chennai 88
Nuremberg 85
Brussels 83
Padova 83
Philadelphia 82
Montreal 81
Amsterdam 78
Johannesburg 78
Brno 77
Denver 77
Mexico City 76
Sterling 76
Kunming 73
Stockholm 72
Las Vegas 71
Baghdad 70
Miami 69
Nanjing 69
Turku 69
Saint Petersburg 68
Tashkent 68
Naples 66
Paris 66
Belo Horizonte 65
Lancaster 65
Totale 87.525
Salva come PNG Salva come JPEG
Nome #
SPLENECTOMY AFTER INITIAL THERAPY WITH ALPHA-IFN IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL) - A MULTICENTER STUDY BY THE ITALIAN COOPERATIVE GROUP FOR HCL - PRELIMINARY-RESULTS 2.646
Hb Hasharon: studio di un nucleo familiare 1.467
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12 1.134
Eritropoiesi extramidollare intratoracica. Considerazioni clinico radiologiche su due casi di talassemia minor 1.105
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 Trial 910
Cancer profile in Eastern Libya: incidence and mortality in the year 2004. 785
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 768
Epidemiological overview of Hodgkin lymphoma across the Mediterranean Basin 757
Cancer incidence in eastern Libya: The first report from the Benghazi Cancer Registry, 2003 745
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial 736
Estimates of cancer burden in Italy 698
Pattern of cancer risk in person with AIDS in Italy inthe HAART era 690
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi 680
Risk assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas. 672
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma 620
IMPACT Working Group: effectiveness of service screening: a case-control study to assess breast cancer mortalità reduction. 592
Caratterizzazione morfo-funzionale delle cellule reticolari dendritiche. 548
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 531
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial. 514
Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients 510
T-cell lymphoma in South America and Europe. 495
Il linfoma mantellare 490
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 485
The Value and Relevance of the T Cell Lymphoma Registries and International Collaborations: the Case of COMPLETE and the T-Cell Project 477
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women 468
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 467
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 460
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial 440
Transformed follicular lymphoma 432
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas 425
Splenic marginal zone lymphoma: a prognostic model for clinical use. 421
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 407
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias. 397
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study 394
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. 391
Identification of protein clusters predictive of response to chemotherapy in breast cancer patients 387
Follicular lymphoma international prognostic index. 384
Prognosis and treatment of micrometastatic breast cancer sentinel lymph node: a population-based study. 382
Use of 2-(18F)fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy 378
Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study 377
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma 376
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations 373
Absolute monocyte count and lymphocyte-monocyte ratio predict outcome in nodular sclerosis Hodgkin lymphoma: Evaluation based on data from 1450 patients 372
Treatment of indolent B-cell nonfollicular lymphomas: Final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi 370
Protein expression patterns associated with advanced stage ovarian cancer 368
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma - The experience of the gruppo italiano studio linfomi 367
Revised response criteria for malignant lymphoma. 364
The outcome of peripheral t-cell lymphoma patients failing first-line therapy: A report from the prospective, international t-cell project 363
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy 362
Defining the best cut-off value for lymphopenia in diffuse large B cell lymphoma treated with immuno-chemotherapy 361
PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract 359
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 359
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfom 354
Prognosis of follicular lymphomas 353
Collective evidence supports neutrality of BRCA1 V1687I, a novel sequence variant in the conserved THV motif of the first BRCT repeat 349
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 349
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study. 348
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience 342
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? 338
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score: long-term results of the GISL LA03 study 336
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines 335
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 333
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 332
Patologia non neoplastica del follicolo linfatico 332
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: Results of a prospective, multicenter study of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 331
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 331
Concordance between four European centre of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. 331
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project 329
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study 328
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network 320
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: Results of a large multicenter study involving 990 patients 318
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study 318
Anthracyclines: A cornerstone in the management of non-Hodgkin's lymphoma 313
Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. 313
Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes 312
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 312
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 311
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 310
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: Final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi 310
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study 309
Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies 309
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis 309
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi 307
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 306
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi 306
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma 306
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias 306
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence 304
Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi 303
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients 303
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 302
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 300
MRI in high risk women: benefits and problems 300
A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL) 300
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies 300
Cancer incidence, mortality, and survival in Eastern Libya: Updated report from the Benghazi Cancer Registry 299
Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer: Issues and Clinical Implications 299
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 298
Risk of second primary malignancy in breast cancer survivors: A nested population-based case-control study 296
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma 296
Totale 45.305
Salva come PNG Salva come JPEG
Categoria #
all - tutte 444.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 444.686
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.962 0 0 0 0 0 0 0 0 0 0 1.041 921
2021/202210.326 412 1.345 1.253 792 318 521 595 613 1.063 702 1.648 1.064
2022/20239.560 1.030 904 643 809 1.197 1.460 252 1.007 1.216 176 504 362
2023/20247.788 329 433 421 538 1.590 462 812 1.163 160 285 698 897
2024/202520.442 1.371 985 282 1.360 3.611 2.588 1.652 1.112 2.434 717 1.894 2.436
2025/202632.516 2.138 1.587 3.224 3.762 5.056 2.801 4.332 1.999 3.478 3.260 879 0
Totale 127.020